By adding HealthShares exchange traded funds (ETFs) into your portfolio you might help America overcome its budget crisis. As of now, the U.S. spends around $2 trillion in health care with an escalating rate of 9% per year. Carl Delfeld for Forbes reports that by continuing to treat disease symptoms with prescription drugs, demographic trends in America will force expenditures to explode as well as the government budget that covers most of these costs for seniors.
Jeffrey Feldman, founder of HealthShares, has a rationale for his rapidly expanding family of ETFs. The idea is to prevent disease instead of treat it, or make breakthroughs in areas that cure ailments such as diabetes. Around half of the phase III clinical trials for entrepreneurial firms are from mid-, small- and micro-cap companies. ETFs are here to help investors put their money into getting these companies off the ground and into alternative medicine to help America. Some HealthShares ETFs include:
- HealthShares Cardiology ETF (HRD)
- HealthShares Neuroscience (HHK)
- HealthShares Emerging Cancer (HHJ)
- HealthShares Respiratory/Pulmonary (HHR)
The opinions and forecasts expressed herein are solely those of Tom Lydon, and may not actually come to pass. Information on this site should not be used or construed as an offer to sell, a solicitation of an offer to buy, or a recommendation for any product.